Aim Immunotech Inc. (AIM) Stock Price & Analysis
Aim Immunotech Inc. (AIM) fell 2.61% to USD 0.23 as of September 8, 2026 at 09:00 UTC, according to Nexqual real-time market data.
AIM last closed at USD 0.23; the session ranged USD 0.23–0.24 on volume of 8,451,417 shares. Market capitalization is —, with a 52-week range of USD 0.19–2.89 (ASE). Source: Nexqual, September 8, 2026 at 09:00 UTC.
Key Statistics (as of September 8, 2026 at 09:00 UTC)
| Price | USD 0.23 |
|---|---|
| Change | ▼ 2.61% (down) |
| Previous Close | USD 0.23 |
| Open | USD 0.23 |
| Day Range | USD 0.23 – 0.24 |
| 52-Week Range | USD 0.19 – 2.89 |
| Volume | 8,451,417 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (AIM)
Nexqual's technical model rates AIM "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:00 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 43.75 (neutral) |
| vs SMA50 | Below (USD 0.26) |
| MACD | -0.01 (negative) |
From Aim Immunotech Inc.'s Latest SEC 10-K Filing (filed 2026-03-27)
Partnerships
- Kellner is a Chartered Financial Analyst with over 50 years of investment experience and currently manages his personal and family investments after retiring in 2017 from his career as a portfolio manager at Fiduciary Management, Inc., an investment management firm that he founded in 1980.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AYTU | Aytu BioPharma, Inc. | USD 2.21 | ▼ 3.07% |
| CODX | Co-Diagnostics, Inc. | USD 1.16 | ▲ 0% |
| IBIO | iBio, Inc. | USD 1.31 | ▲ 0% |
| COCP | Cocrystal Pharma, Inc. | USD 1.13 | ▼ 2.59% |
| NNVC | NanoViricides, Inc. | USD 1.12 | ▼ 4.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:00 UTC. This page is informational and not investment advice.